PE Tech Report


Like this article?

Sign up to our free newsletter

PE-backed InMedica and MediCA Group complete EUR100m merger

Private medial chain In Medica, a portfolio company of INVL Baltic Sea Growth Fund has completed a merger with MediCA Group in what is the largest combination in the Lithuanian healthcare clinic market to date.

The newly combined company will have a turnover in the region of EUR90 million, with more than 250 thousand patients. The merged group will now be led by a joint management team, comprising both MediCA Group and InMedica professionals.

Post-transaction, INVL Baltic Sea Growth Fund (through its special purpose vehicle “BSGF Sanus”) remains the largest shareholder with an ownership stake of 45 per cent of InMedica shares, with 40 per cent owned by Latvia’s largest private medicine group Repharm. The remaining 15 per cent is held by Lithuanian company Litgaja (the holding company of founder and CEO Kęstutis Broniukaitis).

Like this article? Sign up to our free newsletter